| abstract |
Provided herein are compounds of formula I, And tautomers thereof, and pharmaceutically acceptable salts and solvates thereof, wherein R 1 , R 2 and R 3 have the meanings given in the specification, are inhibitors of RET kinase and are suitable for use in the treatment and prevention Diseases treatable with RET kinase inhibitors, including RET related diseases and conditions. |